BICYCLE THERAPEUTICS PLC Insider Trading Activity
Every SEC Form 4 insider transaction reported for BICYCLE THERAPEUTICS PLC (BCYC), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are BCYC insiders buying or selling?
In the last 12 months, BICYCLE THERAPEUTICS PLC insiders reported 0 open-market purchases ($0) and 23 sales ($522.7K) — net selling of $522.7K. Since May 2019, Trabud has recorded 152 Form 4 filings for BCYC: 10 buys ($67.1M) and 142 sells ($31.7M).
Source: SEC EDGAR Form 4
Key Statistics (May 2019 – Oct 7, 2026)
Total Form 4 filings
152
SEC EDGAR
Insider filers
24
Insider buys (10)
$67.1M
Insider sells (142)
$31.7M
Insider sentiment
Net buyingNet insider flow of $35.4M in net buying since May 2019, and $522.7K in net selling over the last 12 months.
Recent BCYC insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 7, 2026 | Jennifer Scott Perry | Chief Operating Officer | Sale | 356 | $3.76 | $1.3K | SEC ↗ |
| Oct 6, 2026 | Robert Charles Swanton | Director | Sale | 3.4K | $3.47 | $11.9K | SEC ↗ |
| Oct 6, 2026 | Michael Skynner | CHIEF SCIENTIFIC OFFICER | Sale | 2.4K | $3.49 | $8.5K | SEC ↗ |
| Oct 6, 2026 | Michael Charles Ferguson Hannay | CHIEF PROD & SUPPLY CHAIN OFF | Sale | 1.8K | $3.48 | $6.3K | SEC ↗ |
| Oct 6, 2026 | Jennifer Scott Perry | Chief Operating Officer | Sale | 1.5K | $3.54 | $5.3K | SEC ↗ |
| Oct 6, 2026 | Kevin Lee | CHIEF EXECUTIVE OFFICER | Sale | 7.8K | $3.49 | $27.2K | SEC ↗ |
| Oct 6, 2026 | Travis Alvin Thompson | Chief Financial Officer | Sale | 972 | $3.48 | $3.4K | SEC ↗ |
| Jul 7, 2026 | Jennifer Scott Perry | Chief Operating Officer | Sale | 1.4K | $4.29 | $6.1K | SEC ↗ |
| Jul 7, 2026 | Michael Skynner | CHIEF SCIENTIFIC OFFICER | Sale | 2.4K | $4.28 | $10.2K | SEC ↗ |
| Jul 7, 2026 | Kevin Lee | CHIEF EXECUTIVE OFFICER | Sale | 7.6K | $4.28 | $32.7K | SEC ↗ |
| Jul 7, 2026 | Michael Charles Ferguson Hannay | CHIEF PROD & SUPPLY CHAIN OFF | Sale | 1.8K | $4.28 | $7.5K | SEC ↗ |
| Jul 7, 2026 | Travis Alvin Thompson | Chief Financial Officer | Sale | 923 | $4.27 | $3.9K | SEC ↗ |
| Apr 6, 2026 | Michael Charles Ferguson Hannay | CHIEF PROD & SUPPLY CHAIN OFF | Sale | 1.8K | $4.93 | $8.7K | SEC ↗ |
| Apr 6, 2026 | Travis Alvin Thompson | Chief Financial Officer | Sale | 901 | $4.93 | $4.4K | SEC ↗ |
| Apr 6, 2026 | Jennifer Scott Perry | Chief Operating Officer | Sale | 1.4K | $4.94 | $7.0K | SEC ↗ |
| Apr 6, 2026 | Kevin Lee | CHIEF EXECUTIVE OFFICER | Sale | 7.7K | $4.94 | $38.0K | SEC ↗ |
| Apr 6, 2026 | Michael Skynner | CHIEF SCIENTIFIC OFFICER | Sale | 2.4K | $4.94 | $11.9K | SEC ↗ |
| Jan 7, 2026 | Travis Alvin Thompson | CHIEF ACCOUNTING OFFICER | Sale | 2.4K | $6.64 | $16.1K | SEC ↗ |
| Jan 7, 2026 | Michael Skynner | CHIEF TECHNOLOGY OFFICER | Sale | 6.3K | $6.62 | $41.8K | SEC ↗ |
| Jan 7, 2026 | Michael Charles Ferguson Hannay | CHIEF PROD & SUPPLY CHAIN OFF | Sale | 5.2K | $6.64 | $34.5K | SEC ↗ |
| Jan 7, 2026 | Alistair Milnes | CHIEF OPERATING OFFICER | Sale | 6.7K | $6.63 | $44.1K | SEC ↗ |
| Jan 7, 2026 | Alethia Young | Chief Financial Officer | Sale | 7.6K | $6.62 | $50.5K | SEC ↗ |
| Jan 7, 2026 | Kevin Lee | CHIEF EXECUTIVE OFFICER | Sale | 21.3K | $6.62 | $141.2K | SEC ↗ |
| Oct 6, 2025 | Kevin Lee | CHIEF EXECUTIVE OFFICER | Sale | 5.5K | $8.41 | $46.2K | SEC ↗ |
| Oct 6, 2025 | Michael Skynner | CHIEF TECHNOLOGY OFFICER | Sale | 1.8K | $8.41 | $15.1K | SEC ↗ |
Showing the 25 most recent of 152 Form 4 filings for BICYCLE THERAPEUTICS PLC.
Most active BCYC insiders
- Kevin Lee30 filings
- Michael Skynner16 filings
- Travis Alvin Thompson15 filings
- Alistair Milnes13 filings
- Nicholas Keen13 filings
Ask anything about BCYC insider activity
Use Trabud's AI agent to query BICYCLE THERAPEUTICS PLC's Form 4 history in plain English — "Show me BCYC CEO purchases this year" or compare it against any other ticker.
Open the AI agentBCYC insider trading FAQ
Are BICYCLE THERAPEUTICS PLC insiders buying or selling?
In the last 12 months, BICYCLE THERAPEUTICS PLC insiders reported 0 open-market purchases ($0) and 23 sales ($522.7K) — net selling of $522.7K. Since May 2019, Trabud has recorded 152 Form 4 filings for BCYC: 10 buys ($67.1M) and 142 sells ($31.7M). Over the full record that is net buying of $35.4M.
How many insiders trade BCYC stock?
24 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for BICYCLE THERAPEUTICS PLC. The most recent filing was accepted on Oct 7, 2026.
Where does Trabud get BCYC insider trading data?
All BCYC insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.